| Date | Time | Source | |
| 05/17/2011 | 5:45PM | PRNUS | Quest Diagnostics Successfully Completes Acquisition of Celera
Quest Diagnostics Successfully Completes Acquisition of Celera PR Newswire MADISON, N.J., May 17, 2011 MADISON, N.J., May 17, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the successful completion of its acquisition... More...>> |
| 05/11/2011 | 9:27AM | DJN | Quest Diagnostics To Complete Celera Deal Through Short-Form Merger
DOW JONES NEWSWIRES Quest Diagnostics Inc. (DGX) plans to complete its deal for genetics-diagnostics test developer Celera Corp. (CRA) through a short-form merger, as the company announced that it held 61% of Celera's shares after the closing of tender offer, which had been extended several times. As of Tuesday's deadline... More...>> |
| 05/11/2011 | 8:00AM | PRNUS | Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option
Quest Diagnostics Announces Completion of Final Extension of the Subsequent Offering Period and Intent to Exercise Top-Up Option and Complete Merger PR Newswire MADISON, N.J., May 11, 2011 MADISON, N.J., May 11, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic... More...>> |
| 05/09/2011 | 8:00AM | PRNUS | Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera
Quest Diagnostics Announces Final Extension of Subsequent Offering Period for Shares of Celera Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10th PR Newswire MADISON, N.J., May 9, 2011 MADISON, N.J., May 9, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing... More...>> |
| 05/04/2011 | 8:00AM | PRNUS | Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera
Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera PR Newswire MADISON, N.J., May 4, 2011 MADISON, N.J., May 4, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services... More...>> |
| 05/03/2011 | 8:00AM | PRNUS | Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today
Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed Shares PR Newswire MADISON, N.J., May 3, 2011 MADISON, N.J., May 3, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider... More...>> |
| 04/29/2011 | 2:20PM | ZACKS | Earnings Scorecard: Quest Diagnostics - Analyst Blog
The announcement of Quest Diagnostics’ (DGX) first quarter of fiscal 2011 results as on April 20, 2011, has triggered analysts to revise estimates downwards. Previous quarter highlights Quest Diagnostics reported an adjusted EPS of $1.00 during the first quarter of fiscal 2011, a penny above the Zacks Consensus Estimate... More...>> |
| 04/21/2011 | 10:08AM | ZACKS | LabCorp Beats, Raises EPS Guidance - Analyst Blog
Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter of fiscal 2011. That was way above the Zacks Consensus Estimate of $1.44 and the previous year's adjusted EPS of $1.40. Moreover... More...>> |
| 04/21/2011 | 10:08AM | ZACKS | LabCorp Beats, Raises EPS Guidance - Analyst Blog
Leading lab-testing company Laboratory Corporation of America Holdings (LH) reported adjusted EPS of $1.52 (excluding amortization, restructuring and other special charges) for the first quarter of fiscal 2011. That was way above the Zacks Consensus Estimate of $1.44 and the previous year's adjusted EPS of $1.40. Moreover... More...>> |
| 04/20/2011 | 4:15PM | BW | Celera Provides Update on Recent Scientific Findings on KIF6 and PMA Application
Celera Corporation (NASDAQ:CRA) today provided an update on recent scientific findings pertaining to the KIF6 gene variant and its pre-market approval application (PMA) with the United States Food and Drug Administration (FDA) for its KIF6 Genotyping Assay. In nine previously published peer-reviewed articles on genetic... More...>> |
| 04/20/2011 | 11:09AM | ZACKS | Earnings Preview: Quest Diagnostics - Analyst Blog
Quest Diagnostics (DGX) is scheduled to release its first quarter fiscal 2011 results on Wednesday, April 20, 2011 before the market opens. The company is expected to earn 99 cents during the quarter on $1,806 million in revenues, according to the Zacks Consensus Estimate. Previous Quarter Highlights Quest reported an... More...>> |
| 04/20/2011 | 8:54AM | ZACKS | Quest Diagnostics Beats by a Penny - Analyst Blog
Quest Diagnostics (DGX) reported an adjusted EPS of $1.00 during the first quarter of fiscal 2011, a penny above the Zacks Consensus Estimate and the year-ago quarter. Revenues for the quarter increased 1% year over year to $1.8 billion, in line with the Zacks Consensus Estimate. A 10.5% decline in the number of outstanding... More...>> |
| 04/18/2011 | 2:09PM | MWUS | New Orleans Employees' Retirement System Announces Settlement of Celera Takeover Litigation
The New Orleans Employees' Retirement System ("NOERS"), the Court-appointed lead plaintiff in the case pending in Delaware Chancery Court captioned In re Celera Corporation Shareholder Litigation, Consol. C.A. No. 6304-VCP, is pleased to announce that it has approved a settlement of the action challenging the acquisition... More...>> |
| 04/18/2011 | 11:14AM | PRNUS | Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2, 2011
Quest Diagnostics Extends Tender Offer for all Outstanding Shares of Celera Corporation to May 2, 2011 Enters into Memorandum of Understanding Providing for the Settlement of Merger Agreement Litigation PR Newswire MADISON, N.J., April 18, 2011 MADISON, N.J., April 18, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated... More...>> |
| 04/18/2011 | 10:41AM | DJN | Celera, Quest Diagnostics Lower Breakup Fees To Settle Suits
DOW JONES NEWSWIRES Celera Corp. (CRA) agreed to amend the terms of its sale to Quest Diagnostics Inc. (DGX) to settle lawsuits filed in Delaware and California. Quest Diagnostics agreed in March to acquire Celera, a genetic-diagnostics test developer, through an $8-a-share tender offer. But Biotechnology Value Fund, Starboard... More...>> |
| 04/18/2011 | 9:31AM | BW | Celera Announces Settlement with Putative Class Action Plaintiffs Regarding Acquisition by Quest Diagnostics
Celera Corporation (NASDAQ:CRA) today announced that Celera and other named defendants have today entered into a memorandum of understanding (MOU) with plaintiffs’ counsel in connection with the previously consolidated putative class action lawsuits filed in Delaware and California state court in connection with the... More...>> |
| 04/14/2011 | 11:39AM | ZACKS | Quest Expedites Celera Acquisition - Analyst Blog
Leading diagnostics player, Quest Diagnostics (DGX) took a step forward toward the proposed acquisition of Celera Corporation (CRA). The company recently announced that the waiting period under the HSR Act has expired, though some other conditions are yet to be met. The tender offer to acquire the shares of Celera is supposed... More...>> |
| 04/13/2011 | 10:38AM | PRNUS | Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera
Quest Diagnostics Announces HSR Clearance for the Acquisition of Celera PR Newswire MADISON, N.J., April 13, 2011 MADISON, N.J., April 13, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has... More...>> |
| 04/12/2011 | 12:41PM | MWUS | Brower Piven Files Class Action Suit Against Celera Corporation (NasdaqGS: CRA)
The law firm of Brower Piven, A Professional Corporation, today announced that a class action has been commenced in the United States District Court for the Northern District of California, Case No. 11-cv-1769, on behalf of all persons who held shares of the common stock of Celera Inc. ("Celera") (NASDAQ: CRA) on April... More...>> |
| 04/07/2011 | 3:00PM | ZACKS | LabCorp, Orchid Test DNA - Analyst Blog
Laboratory Corporation of America Holdings (LH) has decided to acquire Orchid Cellmark (ORCH) for $2.80 per share in cash or a total $85.4 million. The offer price represents a 37.31% premium on the closing price of the share as on April 5, 2011. After taking into account Orchid Cellmark’s cash balance LabCorp’s... More...>> |
